JP Patent

JP5781510B2 — ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用

Assigned to ノバルティス アーゲー · Expires 2015-09-24 · 11y expired

What this patent protects

Patent listed against capmatinib-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5781510B2
Jurisdiction
JP
Classification
—
Expires
2015-09-24
Drug substance claim
No
Drug product claim
No
Assignee
ノバルティス アーゲー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.